Historical aspects of vitamin D

Autor: Glenville Jones

Publikováno v: Endocrine Connections, Vol 11, Iss 4, Pp 1-11 (2022)

Vitamin D has many physiological functions including upregulation of intestinal calcium and phosphate absorption, mobilization of bone resorption, renal reabsorption of calcium as well as actions on a variety of pleiotropic functions. It is believed

Externí odkaz: https://doaj.org/article/4c089bc0e65e4083bc8e0aa999fe9117

Osteal and extraosteal effects of vitamin D and its opportunities of medication correction of its deficiency

Autor: V. V. Salukhov, E. A. Kovalevskaya, V. V. Kurbanova

Publikováno v: Медицинский совет, Vol 0, Iss 4, Pp 90-99 (2018)

A well-known crucial role of Vitamin D is in the maintenance of musculoskeletal system. In terms of high prevalence of violations of calcium-phosphorus metabolism, in the following article we will touch upon some aspects bone metabolic dysfunction, c

Externí odkaz: https://doaj.org/article/f0afc966eb824987a5fcfc4379f33695

Design, Synthesis, Evaluation and Structure of Allenic 1α,25‐Dihydroxyvitamin D3 Analogs with Locked Mobility at C‐17

Autor: Miguel A. Maestro, Antonio Mouriño, Gilles Laverny, Régis Lutzing, Ramón Fraga, Enrique Rodriguez-Borges, Julian Loureiro, Natacha Rochel, Kateryna Len

Publikováno v: Chemistry (Weinheim an Der Bergstrasse, Germany)
Chemistry-A European Journal
Chemistry-A European Journal, Wiley-VCH Verlag, 2021, 27 (53), pp.13384-13389. ⟨10.1002/chem.202101578⟩
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
instname
Chemistry-A European Journal, 2021, 27 (53), pp.13384-13389. ⟨10.1002/chem.202101578⟩

Vitamin D receptor ligands have potential for the treatment of hyperproliferative diseases and disorders related to the immune system. However, hypercalcemic effects limit their therapeutical uses and call for the development of tissue‐selective ne

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3508bafd65b0a8d8bf82201845d3e680
http://europepmc.org/articles/PMC8519077

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Etelcalcetide and Paricalcitol in Chronic Kidney Disease: When the Target Is Inflammation

Autor: Luis D’Marco, Ana Checa-Ros, Dionilux Gamero, Carlos Soto, Juan Salazar, Manuel Nava, Valmore Bermúdez, Fabiola Dapena

Publikováno v: Healthcare; Volume 11; Issue 1; Pages: 72

Introduction: secondary hyperparathyroidism (SHP) is frequent in patients with chronic kidney disease (CKD), particularly in those in dialysis. To treat this complication, the current options available include phosphorus restriction, phosphate binder

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75b8dd0e306e17a3f75c7bf306dc7446